Baltimore MD 前列腺癌临床试验
43项针对 前列腺癌的研究正在 Baltimore及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
招募中3 期
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · 距离 9 英里
- 以及另外 1 项
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- 以及另外 2 项
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
招募中2 期
- Johns Hopkins University, Baltimore
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
招募中观察性研究
- Chesapeake Urology Associates, Towson · 距离 8 英里
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
- Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
- Chesapeake Urology ( Site 0009), Towson · 距离 8 英里
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
招募中3 期
- University of Maryland Greenebaum Cancer Center, Baltimore
- Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
招募中3 期
- Research Site, Towson · 距离 8 英里
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
招募中3 期
- Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
招募中观察性研究
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
招募中2 期
- Chesapeake Urology Research Associates, Towson · 距离 8 英里
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
招募中
- Anne Arundel Urology, Annapolis · 距离 22 英里
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Veterans Administration Medical Center-Baltimore, Baltimore
- 以及另外 4 项
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
招募中
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
招募中
- Johns Hopkins Hospital, Baltimore
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
招募中2 期
- University of Maryland Greenebaum Cancer Center, Baltimore
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
招募中1/2 期
- Johns Hopkins Hospital, Baltimore
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
招募中3 期
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
招募中1 期
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
招募中观察性研究
- Johns Hopkins University, Baltimore
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
招募中2 期
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
招募中1 期
- Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore
7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate Cancer
招募中
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
The COSMYC Trial (COmbined Suppression of MYC)
招募中2 期
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
招募中1 期
- Advanced Molecular Imaging and Therapy, Glen Burnie · 距离 9 英里
- United Theranostics - Chesapeake, Glen Burnie · 距离 9 英里
TERPS Trial for de Novo Oligometastic Prostate Cancer
招募中2 期
- Maryland Proton Treatment Center, Baltimore
- UMMC, Baltimore
- Baltimore Washington Medical Center, Glen Burnie · 距离 9 英里
- 以及另外 1 项
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
招募中观察性研究
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Clinical Trial of Approaches to Prostate Cancer Surgery
招募中
- Johns Hopkins University, Baltimore
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
招募中2/3 期
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore
SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
招募中观察性研究
- Johns Hopkins University, Baltimore
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
招募中2 期
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
招募中2 期
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
招募中早期 I 期
- SKCCC at Johns Hopkins, Baltimore
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
招募中1 期
- Chesapeake Urology, Towson · 距离 8 英里
Physician- and Patient-based Barriers to NGS Testing
招募中
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
招募中2 期
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
招募中1 期
- Johns Hopkins Hospital, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 距离 8 英里
Exercise in Prostate Cancer
招募中
- Johns Hopkins University, Baltimore
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
招募中1/2 期
- Johns Hopkins, Baltimore
其他城市的 前列腺癌试验
- New York City, NY103 项研究
- Houston, TX76 项研究
- Los Angeles, CA61 项研究
- Boston, MA59 项研究
- St. Louis, MO46 项研究
- Chicago, IL45 项研究
- San Francisco, CA45 项研究
- Philadelphia, PA44 项研究
- Nashville, TN42 项研究
- Seattle, WA42 项研究
- Washington, DC38 项研究
- Dallas, TX36 项研究
Baltimore的其他研究
- 非小细胞肺癌60 项研究
- 乳腺癌47 项研究
- 肺癌40 项研究
- 癌症（所有类型）37 项研究
- 结直肠癌31 项研究
- 胰腺癌31 项研究
- 转移性癌症28 项研究
- 肥胖症25 项研究
- 心力衰竭24 项研究
- 膀胱癌24 项研究
- 卒中22 项研究
- 卵巢癌22 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。